Subscribe To

Price Alert Latest News Economic Calendar News

BVS / Bioventus Inc. (BVS) CEO name on Q1 2022 Results - Earnings Call Transcript

Bioventus Inc. (NASDAQ:BVS ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Dave Crawford - Vice President of Investor Relations Ken Reali - Chief Executive Officer Mark Singleton - Senior Vice President and Chief Financial Office Conference Call Participants Alex Nowak - Craig Hallum Operator Good day and thank you for standing by. Welcome to Bioventus First Quarter 2022 Earnings Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Bioventus

Inc

BVS

Name

2022

Results

Earnings

Call

Transcript

Stock

Posted: May 10 2022, 14:22

Author Name: Seeking Alpha

BVS News

By GlobeNewsWire
October 31, 2023

Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023

DURHAM, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations fo

By Seeking Alpha
October 11, 2023

Bioventus Stock: Improving Outlook Keeps It Interesting

Bioventus Inc. is attempting to move forward from disappointing results in recent years including the failed acquisition of "CartiHeal." The company e

By Zacks Investment Research
September 28, 2023

3 Value Medical Stocks to Buy for Safety Amid Market Volatility

We have narrowed our search to three value stocks from the Medical sector. These are PHG, RDNT and BVS.

By GlobeNewsWire
September 19, 2023

Bioventus to Present at the Cantor Global Healthcare Conference

DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that

By GlobeNewsWire
September 6, 2023

Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that

By PennyStocks
August 16, 2023

7 Penny Stocks To Buy According To Insiders In August

Investing in penny stocks represents an enticing prospect for those seeking to leverage the stock market's potential gains. Characterized by an inhere

By PennyStocks
August 15, 2023

4 Penny Stocks To Buy According To Insiders In August

Penny stocks provide a captivating opportunity for those aiming to profit in the stock market. The intrinsic risk and potential rewards associated wit

By Seeking Alpha
August 12, 2023

Bioventus Inc. (BVS) Q2 2023 Earnings Call Transcript

Bioventus Inc. (NASDAQ:BVS ) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Dave Crawford - VP, IR Tony Bihl - CEO Mar

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.